ESC

Infective Endocarditis: AHA 2026 vs ESC 2023

by
Early 20th-century doctor staring fearfully into a microscope as ghostly, alien-like microorganisms emerge from the slide in a dimly lit hospital ward.

Introduction On September 8, 2026, Circulation published the new American Heart Association scientific statement on infective endocarditis (IE) — the first comprehensive AHA document on the subject since 2015 [1]. Ten years is a long time in endocarditis. The patients have changed over that interval. Cardiovascular prostheses and transcatheter devices are now everywhere, molecular microbiology … Read more

Percutaneous Interventions Expand: Key Insights from 2025 ESC/EACTS Guidelines

by
In an early-20th-century hospital room, two masked surgeons confer with a formally dressed man beside a reclining patient, surrounded by anatomical sketches, scientific diagrams, glass infusion bottles, and antique medical instruments.

Introduction The 2025 ESC/EACTS Guidelines on Valvular Heart Disease represent a pivotal shift in the balance between surgical and percutaneous interventions. While surgical aortic valve replacement (SAVR) remains the gold standard for younger, low-risk patients, the new guidelines expand the role of transcatheter aortic valve implantation (TAVI) and transcatheter edge-to-edge repair (TEER, MitraClip). This evolution … Read more